Azuraophthalmics
Founded 2014 · 11 employees on LinkedIn · 1 known investors
Find your way into Azuraophthalmics
Azura Ophthalmics develops a new therapeutic class of ophthalmic keratolytics aimed at treating lid margin and ocular surface diseases and other underserved ophthalmic conditions. The company applies drug development expertise to address the core pathophysiology of these eye conditions.
Founders & leadership
L
LubaDirector of Pre-Clinical Development
Investors · 1
Frequently asked questions
- What does Azuraophthalmics do?
- Azura Ophthalmics develops a new therapeutic class of ophthalmic keratolytics aimed at treating lid margin and ocular surface diseases and other underserved ophthalmic conditions. The company applies drug development expertise to address the core pathophysiology of these eye conditions.
- Who are Azuraophthalmics's investors?
- Azuraophthalmics's investors include OrbiMed.